The Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional) research funding from the National Institutes of Health (NIH) supports research on understanding the neurological and neuropsychiatric manifestations of COVID-19 (neuro-COVID) and Post-Acute Sequelae of SARS-CoV-2 Infection (neuro-PASC) and on the effect of COVID-19 on pre-infection neurologic conditions. Applications investigating the pathophysiology and mechanisms of neuro-COVID and neuro-PASC and neurologically-focused human subjects research, as well as those proposing studies of scientifically compelling pathways to prevent the development of neuro-PASC or to accelerate the development of effective treatments for PASC-related neurological complications are of particular interest. The grant provides 500,000 USD for up to 5 years. Applicants must be conducting research as US-based institutions.
Funding opportunity number: RFA-NS-23-021.
Letters of intent are due on January 2, 2024. Applications close on: February 2, 2024.
February 2, 2024